In fact, APOE ε4 carriers have increased amyloid plaques and phosphorylated tau in their brains and may be involved in other processes, such as mitochondrial dysfunction or impairment of mitochondrial motility; although the specific mechanisms are still under discussion [150] and may constitute a link between cholesterol levels and AD independent of cardiovascular disease. This evidence concerns the gene MAPT and Alzheimer disease.